open access

Vol 29, No 1 (2022)
Original Article
Submitted: 2021-07-16
Accepted: 2021-11-22
Published online: 2021-12-17
Get Citation

Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis

Artur Filipecki1, Michał Orszulak1, Mateusz Tajstra2, Oskar Kowalski3, Michał Skrzypek4, Zbigniew Kalarus5, Mariusz Gąsior2, Katarzyna Mizia-Stec1
DOI: 10.5603/CJ.a2021.0170
·
Pubmed: 34931693
·
Cardiol J 2022;29(1):27-32.
Affiliations
  1. 1st Chair and Department of Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  2. 3rd Chair and Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  3. Department of Human Nutrition, School of Public Health in Bytom, Silesian Center of Heart Disease in Zabrze, Medical University of Silesia, Katowice, Poland
  4. Department of Biostatistics, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland
  5. 2nd Chair and Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland

open access

Vol 29, No 1 (2022)
Original articles — COVID-19
Submitted: 2021-07-16
Accepted: 2021-11-22
Published online: 2021-12-17

Abstract

Background: Coronavirus disease 2019 (COVID-19) pandemic disorganised healthcare systems and has caused a reduction in the number of hospitalizations and procedures. Cardiac implantable electronic device (CIED) procedure rates and clinical characteristics of their recipients were compared in corresponding weeks of 2019 and 2020 were analyzed.
Methods: The database of the National Health Fund (NHF) in Poland was retrospectively analyzed. 3206 patients who underwent CIED implantation in the Silesia — a region in Southern Poland comprising an adult population of 3.8 million between 12th and 31st week of 2020. Patients were classified into groups: the recipient of an implantable cardioverter-defibrillator or cardiac resynchronization therapy group (ICD/CRT) or pacemaker group (PM).
Results: During the pandemic a reduction of 39.38% of implantations was observed compared to the same period in 2019 (1210 vs. 1996 patients) and had impacted both groups. Two phases lasting 10 weeks each could be distinguished: total lockdown (maximal reduction) and the recovery phase with growing numbers of procedures. Patient baseline characteristics (sex, age, comorbidities) who were implanted during the COVID-19 pandemic did not differ from the 2019 period. The rate of peri-procedural mortality was also similar.
Conclusions: During COVID-19 pandemic period a reduction in CIED implantations of all types was observed. Despite the decreased number of performed CIED implants, no differences in baseline patient characteristics were observed.

Abstract

Background: Coronavirus disease 2019 (COVID-19) pandemic disorganised healthcare systems and has caused a reduction in the number of hospitalizations and procedures. Cardiac implantable electronic device (CIED) procedure rates and clinical characteristics of their recipients were compared in corresponding weeks of 2019 and 2020 were analyzed.
Methods: The database of the National Health Fund (NHF) in Poland was retrospectively analyzed. 3206 patients who underwent CIED implantation in the Silesia — a region in Southern Poland comprising an adult population of 3.8 million between 12th and 31st week of 2020. Patients were classified into groups: the recipient of an implantable cardioverter-defibrillator or cardiac resynchronization therapy group (ICD/CRT) or pacemaker group (PM).
Results: During the pandemic a reduction of 39.38% of implantations was observed compared to the same period in 2019 (1210 vs. 1996 patients) and had impacted both groups. Two phases lasting 10 weeks each could be distinguished: total lockdown (maximal reduction) and the recovery phase with growing numbers of procedures. Patient baseline characteristics (sex, age, comorbidities) who were implanted during the COVID-19 pandemic did not differ from the 2019 period. The rate of peri-procedural mortality was also similar.
Conclusions: During COVID-19 pandemic period a reduction in CIED implantations of all types was observed. Despite the decreased number of performed CIED implants, no differences in baseline patient characteristics were observed.

Get Citation

Keywords

COVID-19, cardiac implantable electronic devices, pacemakers, implantable cardioverter-defibrillator, cardiac resynchronization therapy, pandemic

About this article
Title

Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis

Journal

Cardiology Journal

Issue

Vol 29, No 1 (2022)

Article type

Original Article

Pages

27-32

Published online

2021-12-17

Page views

2852

Article views/downloads

607

DOI

10.5603/CJ.a2021.0170

Pubmed

34931693

Bibliographic record

Cardiol J 2022;29(1):27-32.

Keywords

COVID-19
cardiac implantable electronic devices
pacemakers
implantable cardioverter-defibrillator
cardiac resynchronization therapy
pandemic

Authors

Artur Filipecki
Michał Orszulak
Mateusz Tajstra
Oskar Kowalski
Michał Skrzypek
Zbigniew Kalarus
Mariusz Gąsior
Katarzyna Mizia-Stec

References (10)
  1. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. 2020; 17(9): e233–e241.
  2. Kempa M, Gułaj M, Farkowski MM, et al. Electrotherapy and electrophysiology procedures during the coronavirus disease 2019 pandemic: an opinion of the Heart Rhythm Section of the Polish Cardiac Society (with an update). Kardiol Pol. 2020; 78(5): 488–492.
  3. Gąsior M, Pres D, Wojakowski W, et al. Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database. Pol Arch Med Wewn. 2016; 126(10): 754–762.
  4. Migliore F, Zorzi A, Gregori D, et al. Urgent pacemaker implantation rates in the veneto region of italy after the COVID-19 outbreak. Circ Arrhythm Electrophysiol. 2020; 13(6): e008722.
  5. Gonzales-Luna AC, Torres-Valencia JO, Alarcón-Santos JE, et al. Impact of COVID-19 on pacemaker implant. J Arrhythm. 2020 [Epub ahead of print]; 36(5): 845–848.
  6. Marini M, Zilio F, Martin M, et al. COVID-19 pandemic and elderly: is the curtain dropped for urgent pacemaker implantations? Minerva Cardioangiol. 2020 [Epub ahead of print].
  7. Chew QH, Wei KC, Vasoo S, et al. Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic. Singapore Med J. 2020; 61(7): 350–356.
  8. De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol. 2020; 76(20): 2321–2330.
  9. Bollmann A, Pellissier V, Hohenstein S, et al. Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes. 2021; 7(4): e5–e6.
  10. Boriani G, Palmisano P, Guerra F, et al. Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med. 2020; 15(8): 1445–1456.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl